Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation

Inflammation Research

Volumn 55, Issue 9, 2006, Pages 359-363

  Yasui, K ^a   Baba, A ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Neutrophils; Resolution of inflammation; Superoxide dismutase

Indexed keywords

CASPASE 3; CHEMOKINE; COPPER ZINC SUPEROXIDE DISMUTASE; FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 18; LIPOSOME; MACROGOL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTHRITIS; BURN; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; ENCAPSULATION; ENZYME ACTIVATION; ENZYME MODIFICATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; INFLAMMATION; LEUKOCYTE; LUNG DISEASE; MACROPHAGE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SKIN DISEASE; SUSTAINED DRUG RELEASE; T LYMPHOCYTE; TRANSGENIC ANIMAL; WOUND;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; HUMANS; INFLAMMATION; NEUTROPHILS; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 34347242634     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-5195-y     Document Type: Review

References (56)

1. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
2. Quinlan GJ, Evans TW, Gutteridge JM. Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free Radic Res 1994; 20: 289-98.
3. Morpurgo E, Cadrobbi R, Morpurgo M, Rigotti P, Schiavon F, Schiavon O et al. Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury. Transplantation 1996; 62: 1221-3.
4. Park JL, Lucchesi BR. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 1999; 68: 1905-12.
5. McGee DJ, Mobley HL. Mechanisms of Helicobacter pylori infection: bacterial factors. Curr Top Microbiol Immunol 1999; 241: 155-80.
6. Seligmann C, Bock A, Leitsch T, Schimmer M, Simsek Y, Schultheiss H-P. Polymorphonuclear granulocytes induce myocardial dysfunction during ischemia and later reperfusion of hearts exposed to low-flow ischemia. J Leukoc Biol 2001; 69: 727-31.
7. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003; 31: S195-S199.
8. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101: 3765-77.
9. Abela CB, Homer-Vanniasinkham S. Clinical implication of ischaemia-reperfusion injury. Pathophysiology 2003; 9: 229-40.
10. Salvemini D, Wang ZQ, Zweier JL, Samouilov A, Macarthur H, Misko TP et al. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 1999; 286: 304-6.
11. Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MG, Macarthur H et al. Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br J Pharmacol 1999; 127: 685-92.
12. Burton KP. Superoxide dismutase enhances recovery following myocardial ischemia. Am J Physiol 1985; 248: H637-43.
13. Lasheras C, Huerta JM, Gonzalez S, Brana AF, Patterson AM, Fernandez S. Independent and interactive association of blood antioxidants and oxidative damage in elderly people. Free Radic Res. 2002; 36: 875-82.
14. Tamagawa K, Taooka Y, Maeda A, Hiyama K, Ishioka S, Yamakido M. Inhibitory effects of a lecithinized superoxide dismutase on bleomysin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 2000; 161: 1279-84.
15. Sharpe MA, Ollosson R, Stewart VC, Clark JB. Oxidation of nitric oxide by oxomanganese-salen complexes: a new mechanism for cellular protection by superoxide dismutase/catalase mimetics. Biochem J 2002; 366: 97-107.
16. Wang W, Jittikanont S, Falk SA, Li P, Feng L, Gengaro PE et al. Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol 2003; 284: F532-F537.
17. Kobayashi SD, Voyich JM, Somerville GA, Braughton KR, Malech HL, Musser JM et al. An apoptosis-differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation. J Leukoc Biol 2003; 73: 315-22.
18. Yasui K, Kobayashi N, Yamazaki T, Agematsu K, Matsuzaki S, Ito S et al. Superoxide dismutase (SOD) as a potential inhibitory mediator of inflammation via neutrophil apoptosis. Free Radic Res 2005; 39: 755-62.
19. Savill J. Apoptosis is resolution of inflammation. J Leukoc Biol 1997; 61: 375-80.
20. Ho YS, Vincent R, Dey MS, Slot JW, Crapo JD. Transgenic models for the study of lung antioxidant defence: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol 1998; 18: 538-47.
21. Sohal RS, Agarwal A, Agarwal S, Orr WC. Simultaneous overexpression of copper- and zinc-containing superoxide dismutase and catalase retards age-related oxidative damage and increases metabolic potential in Drosophila melanogaster. J Biol Chem 1995; 270: 15671-4.
22. Wheeler MD, Nakagami M, Bradford BU, Uesugi T, Mason RP, Connor HD et al. Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat. J Biol Chem 2001; 276: 36664-72.
23. McCord JM. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science 1974; 185: 529-31.
24. Safford SE, Oberley TD, Urano M, St Clair DK. Suppression of fibrosarcoma metastasis by elevated expression of manganese dismutase. Cancer Res. 1994; 54: 4261-5.
25. Chen Z, Oberley TD, Ho Y, Chua CC, Siu B, Hamdy RC et al. Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. Free Radic Biol Med 2000; 29: 589-96.
26. Barnes JP. Theophylline in chronic obstructive pulmonary disease: new horizons. Proc Am Thorac Soc 2005; 2: 334-9.
27. Salminen U, Harjula AL, Maasilta PK, Romanska HM, Bishop AE, Polak JM. Superoxide dismutase in development of obliterative bronchiolitis. Transplant Proc 2001; 33: 2477.
28. Corvo ML, Boerman OC, Oyen WJ, Van Bloois L, Cruz ME, Crommelin DJ et al. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta 1999; 1419(2): 325-34.
29. Flohe L. Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes. Mol Cell Biochem 1988; 84: 123-31.
30. Niwa Y. Lipid peroxides and superoxide dismutase (SOD) induction in skin inflammatory diseases, and treatment with SOD preparations. Dermatologica 1989; 179: S101-S106.
31. Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Aston K, Riley DP et al. Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br J Pharmacol 2001; 132: 19-29.
32. Masini E, Cuzzocrea S, Mazzon E, Marzocca C, Mannaioni PF Salvemini D. Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo. Br J Pharmacol 2002; 136: 905-17.
33. Salvemini D, Mazzon E, Dugo L, Riley DP, Serraino I, Caputi AP et al. Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br J Pharmacol 2001; 132: 815-27.
34. Aldridge AJ. Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg 2002; 168: 204-14.
35. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999; 160: S5-S11.
36. Fantone JC, Ward PA. A review: role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982; 107: 395-418.
37. Ghio AJ, Suliman HB, Carter JD, Abushamaa AM, Folz RJ. Overexpression of extracellular superoxide dismutase decreases lung injury after exposure to oil fly ash. Am J Physiol Lung Cell Mol Physiol 2002; 283: L211-L218.
38. Kawabori S, Soda K, Perdue MH, Bienenstock J. The dynamics of intestinal eosinophils depletion in rats treated with dexamethasone. Lab Invest 1991; 64: 224-33.
39. Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995; 86: 3181-8.
40. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. J Immunol 1995; 154: 4719-25.
41. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156: 4422-8.
42. Hannah S, Mecklenburgh K, Rahman I, Bellingan GJ, Greening A, Haslett C et al. Hypoxia prolongs neutrophil survival in vitro. FEBS Lett 1995; 372: 233-7.
43. Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Seki H et al. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 1997; 89: 1748-53.
44. Brown JR, Goldblatt D, Buddle J, Morton L, Thrasher AJ. Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage pahgocytosis in chronic granulomatous disease (CGD). J Leukoc Biol 2003; 73: 591-9.
45. Fadeel B, Ahlin A, Henter J-I, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 1998; 92: 4808-18.
46. Scheel-Toellner D, Wang K, Craddock R, Webb PR, McGettrick HM, Assi LK et al. Reactive oxygen species limit neutrophil lifespan by activating death receptor signaling. Blood 2004; 104: 2557-64.
47. Shimura M, Osawa Y, Yuo A, Hatake K, Takaku F, Ishizaka Y. Oxidative stress as a necessary factor in room temperature-induced apoptosis of HL-60 cells. J Leukoc Biol 2000; 68: 87-96.
48. Lundqvist-Gustafsson H, Bengtsson T. Activation of the granule pool of the NADPH oxidase accelerates apoptosis in human neutrophils. J Leukoc Biol 1999; 65: 196-204.
49. Yasui K, Shinozaki K, Nakazawa T, Agematsu K, Komiyama A. Presenility of granulocytes in Down syndrome individuals. Am J Med Genet 1999; 84: 406-12.
50. Blatt J, Albo V, Prin W, Orlando S, Wollman M. Excessive chemotherapy-related myelotoxicity in children with Down syndrome and acute lymphoblastic leukaemia. Lancet 1986; 8512: 914.
51. Zwaan CM, Kaspers GJ, Pieters R, Hahlen K, Janka-Schaub GE, van Zantwijk CH et al. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Blood 2002; 99: 245-51.
52. Ho Y-S, Xiong Y, Ma W, Spector A, Ho DS. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 2004; 279: 32804-12.
53. Corvo ML, Boerman OC, Oyen WJG., Jorge JCS, Cruz MEM, Crommelin DJA et al. Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an inflammation model. Pharm Res 2000; 17: 600-6.
54. Salvemini D, Cuzzocrea S. Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine. Crit Care Med 2003; 31: S29-S38.
55. Baret A, Jadot G, Michelson AM. Pharmacokinetic and antiinflammatory properties in the rat of superoxide dismutases (Cu SODs and Mn SOD) from various species. Biochem Pharmacolol 1984; 33: 2755-60.
56. Rengel RG., Filipovic-Grcic J, Cepelak I, Zanic-Grubisic T, Barisic K. The effect of liposomes with superoxide dismutase on A2182 cells. Eur J Pharm Biopharm 2005; 60: 47-51.